Qube Research & Technologies (QRT)’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Qube Research & Technologies (QRT)'s ATRC Position: Q2 2026 in Review
Qube Research & Technologies (QRT) increased its AtriCure (ATRC) stake by 23% in Q2 2026, buying an estimated $2.98M and bringing the position to 560,824 shares worth $15.7M. The position accounts for 0.01% of the portfolio, ranked #1029.
Qube Research & Technologies (QRT) first reported a position in ATRC in Q2 2020 and has held it in 15 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Qube Research & Technologies (QRT) held 560,824 shares of AtriCure worth $15.7M as of Q2 2026.
- Qube Research & Technologies (QRT) bought 106,033 AtriCure shares in Q2 2026, an estimated $2.98M.
- AtriCure made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1029 holding.
- Qube Research & Technologies (QRT) first reported a position in AtriCure in Q2 2020 and has held it in 15 quarters since.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.